Presentation is loading. Please wait.

Presentation is loading. Please wait.

A Novel, Countermeasure- proof, P300-Based Protocol for Detection of Concealed Information J.Peter Rosenfeld, Michael Winograd, Elena Labkovsky, Ann Ming.

Similar presentations


Presentation on theme: "A Novel, Countermeasure- proof, P300-Based Protocol for Detection of Concealed Information J.Peter Rosenfeld, Michael Winograd, Elena Labkovsky, Ann Ming."— Presentation transcript:

1 A Novel, Countermeasure- proof, P300-Based Protocol for Detection of Concealed Information J.Peter Rosenfeld, Michael Winograd, Elena Labkovsky, Ann Ming Lui Department of Psychology Institute for Neuroscience Northwestern University

2 Previous P300 DD protocols used Separate Probe(P),Irrelevant(I) and Target(T) trials. 80% to 95% correct detection rates….but…. *Rosenfeld et al. (2004) and Mertens, Allen et al. (2007):These methods are vulnerable to Counter-measures (CMs) via turning I’s into covert T’s.

3 Results from Rosenfeld et al. (2004): Farwell-Donchin paradigm (BAD and BCAD are 2 analysis methods.) Diagnoses of Guilty Guilty Group Innocent Group CM Group 9/11(82 %) 1/11(9%) 2/11(18%) Amplitude Difference (BAD) method,p=.1 Cross-Correlation(BC-AD ) Method, p=.1 6/11(54 %) 0/11(0%) 6/11(54 %)

4 Results (hit rates) from Rosenfeld et al. (2004): Rosenfeld paradigm Week BAD* BC-AD* 1: no CM 12/13(.92) 9/13(.69) 2: CM 6/12(.50) 3/12(.25) 3: no CM 7/12(.58) 3/12(.25) *Note: BCD and BAD are 2 kinds of analytic bootstrap procedures.

5 In the “Complex Trial Protocol,” P/I and T/NT decisions are separated: Two stimuli per trial, 1.2-1.5 s apart. The first is P or I presented in white font. The second is the same P or I presented either in T color (green) or one of 4 non- T colors (red, yellow, etc.) (The second could also be T and NT numbers, or whatever.)

6

7 4 STIMULUS TYPES STIMULUS TYPE NUMBER PROBABILITY Probe Target 30.09 Probe non-Target 30.09 Irrelevant Target 30.09 Irrelevant non-Target 240.73 All Probes 60.18 Oddballs 90.27 One probe and 4 irrelevants P (T/P) =.5… vs… P (T/I) =.11 (Confound?)

8 DESIGN: as in ’04 paper, Exp. 2: 3 weeks in one group Week 1 Naïve Week 2 CM Week 3 Repeat Week 1 One block with one probe type, but category varied and counterbalanced across subjects/weeks: 1)mother’s first names 2) family surnames 3) home towns Main Study plus near replication. Innocent Control Group for FPs.

9 Countermeasures in Week 2: Also as in ’04 paper Left finger press to Irrelevant # 1 Left toe wiggle to Irrelevant # 2 Right toe wiggle to Irrelevant # 3 Imagine Prof slaps you for Irrelevant#4 All these are done covertly so that operator cannot detect them.

10

11

12 RTs (all stimuli). Replication like ‘04 study: no overlap.

13 P & I Individual RTs in CT Protocol (Flat liner at bottom did not beat test.)

14 Statistical tests within each subject: T/F-tests comparing Week 1 RT or RT Variance versus Week 2 are all p<.01, and <.001 in the one subject who beat the test in Week 2. Thus CM use is detectable.

15 In ’04 paper (old protocol), probe declines over weeks:

16 NEW RESULTS: P300s

17 P300, p-p

18 Two* possible (P-I) tests: 1)Traditional: Probe versus mean of all Irrelevants, P vs I-All. 2)Probe versus Maximum Irrelevant P vs I-max (“simple hit”) or Probe versus I-max not associated with elevated RT (“RT-screened Hit”). * at.9 or.95 confidence levels.

19 Main Study. Within-subject correct detections of guilty subjects based on bootstrap comparison of probe P300 against the average of all irrelevant P300s over 3 weeks. WEEK Hit Rate [Hit Rate] Week 1 (no CM): 11/12 (92%) [12/12*( 100%)] Week 2 (CM): 10/11 (91%) [11/12* (92%)] Week 3 (no CM): 11/12 (92%) [12/12* (100%)] Main Study: False positive(FP) group. Confidence=.9 Confidence=.95 Test FPs Hits A’ FPs Hits A’ Iall.08.92.95 0.92.98 Imax 0.92.98 0.92.98

20 Main Study: Simple and RT-qualified diagnoses (at confidence =.9, Probe vs. Imax (or RT-qualified Imax) across 3 weeks (n values in parentheses). CM use also shown. Week 1 (12) Week 2 (11) Week 3 (12) Simple hits.92.73.92 Hits/RT qualified.92.91.92 CM use 0.0 1.0 0.0

21 Near Replication: Within-subject correct detections (“Hits”) of guilty subjects based on bootstrap comparison (at 2 confidence levels) of probe(P) P300 against the average of all irrelevant P300s (I-All) over weeks, and against the largest irrelevant P300 (I-Max). CONFIDENCE LEVEL: 0.90 WEEK P vs I-All: Hits, [FPs], A’ P vs I-Max: Hits, [FPs] A’ 1: 12/12 (100%),[8%].91 11/12 ( 92%), [0%].98 2: 12/12 (100%) 11/12 ( 92%) * 3: 9/10 (90%) 7/10 (70%) CONFIDENCE LEVEL: 0.95 WEEK P vs I-All: Hits, [FPs], A’ P vs I-Max: Hits, [FPs], A’ 1: 11/12 (92%),[0%].98 11/12 ( 92%), [0%].98 2: 12/12 (100%) 11/12 ( 92%) * 3: 9/11 (82%) ** 8/11 (73%)**

22 CTP Mock Crime Study: Preliminary Results. Note Target= 11111. (Mike Winograd’s study)

23 Conclusions (& Why ? ) The complex trial protocol is CM- resistant and accurate in the CIT Context. *The S1 involves no classification or decision, unlike older protocols, whose target classification task is removed, leaving all resources devoted to probe/irrelevant recognition. *CMs force more attention to first stimulus  increased probe (& Irrel) P300s.

24 NEXT? We need to extend CTP to our hybrid CQT screening protocol (Rosenfeld et al., 1991.) We need to try 3-4 blocks a session, each with different probe category. CTP should be even better with more Irrelevants.

25 A Novel, Countermeasure- proof, P300-Based Protocol for Detection of Deception (DD). jp-rosenfeld@northwestern.edu


Download ppt "A Novel, Countermeasure- proof, P300-Based Protocol for Detection of Concealed Information J.Peter Rosenfeld, Michael Winograd, Elena Labkovsky, Ann Ming."

Similar presentations


Ads by Google